CDC Health Alert Network. (2018) Outbreak of life-threatening coagulopathy associated with synthetic cannabinoids use. Atlanta: US Department of Health & Human Services.
External website: https://emergency.cdc.gov/han/han00410.asp
The US Centers for Disease Control and Prevention (CDC) is providing information on: 1) the current status of a multistate outbreak of coagulopathy from exposure to synthetic cannabinoid products containing a vitamin K-dependent antagonist agent, such as brodifacoum; 2) signs and symptoms of presenting patients from this outbreak and which patients are at risk; 3) laboratory testing options that are available to help identify and classify cases; 4) available resources that may help clinicians make decisions; and 5) to whom to report possible cases.
B Substances > New (novel) psychoactive substances > Synthetic cannabinoids (Spice / K2 / OXIZID / HHC)
G Health and disease > State of health
J Health care, prevention, harm reduction and treatment > Patient / client care management
T Demographic characteristics > Doctor / physician
VA Geographic area > United States
Repository Staff Only: item control page